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ABSTRACT
Background  Heat shock proteins (Hsps) play a role 
in the delivery and presentation of antigenic peptides 
and are thought to be involved in the pathogenesis of 
multifactorial diseases.
Objective  To investigate genes encoding cytosolic 
Hsp70 proteins for associations of allelic variants with 
systemic lupus erythematosus (SLE).
Methods  Case–control studies of two independent 
Caucasian SLE cohorts were performed. In a haplotype-
tagging single-nucleotide polymorphism approach, 
common variants of HspA1L, HspA1A and HspA1B were 
genotyped and principal component analyses were 
performed for the cohort from the Oklahoma Medical 
Research Foundation (OMRF). Relative quantiﬁ  cation of 
mRNA was carried out for each Hsp70 gene in healthy 
controls. Conditional regression analysis was performed 
to determine if allelic variants in Hsp70 act independently 
of HLA-DR3.
Results  On analysis of common genetic variants of 
HspA1L, HspA1A and HspA1B, a haplotype signiﬁ  cantly 
associated with SLE in the Erlangen-SLE cohort was 
identiﬁ  ed, which was conﬁ  rmed in the OMRF cohort. 
Depending on the cohorts, OR ranging from 1.43 to 
1.88 and 2.64 to 3.16 was observed for individuals 
heterozygous and homozygous for the associated 
haplotype, respectively. Patients carrying the risk 
haplotype or the risk allele more often displayed 
autoantibodies to Ro and La in both cohorts. In healthy 
controls bearing this haplotype, the amount of HspA1A 
mRNA was signiﬁ  cantly increased, whereas total Hsp70 
protein concentration was not altered.
Conclusions  Allelic variants of the Hsp70 genes 
are signiﬁ  cantly associated with SLE in Caucasians, 
independently of HLA-DR3, and correlate with the 
presence of autoantibodies to Ro and La. Hence, 
the Hsp70 gene locus appears to be involved in SLE 
pathogenesis.
Heat shock proteins (Hsps) have been discov-
ered as a result of their inducible expression in 
response to endogenous and exogenous stimuli 
such as elevated temperature, osmotic shock and 
the presence of cytotoxic agents.1 Functionally, 
most Hsps act as molecular chaperones by selec-
tively recognising and binding non-native proteins, 
thereby preventing irreversible aggregation under 
physiological and stress conditions.2 By virtue of 
their peptide binding ability, this protein family 
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modulates antigen processing and presentation 
and also contributes to immune responses against 
pathogens.3–5 Hsps are fundamental regulatory 
elements of cellular networks as they interact 
with a large number of proteins such as kinases, 
transcription factors and several other proteins 
inﬂ  uencing key steps in protein homoeostasis, cell 
growth, division, apoptosis and development.6 7 
It has been shown that mutations and polymor-
phisms in chaperones, particularly Hsp70, are 
associated with several human, mostly immune-
mediated, diseases such as multiple sclerosis,8 
Crohn’s disease,9 Alzheimer’s disease,10 Grave’s 
disease,11 insulin-dependent diabetes mellitus12 
and systemic lupus erythematosus (SLE).13 14 The 
chronic inﬂ   ammatory autoimmune disease SLE 
involves multiple organs, including skin, joints, 
kidneys, brains, the cardiovascular system and 
serosal membranes. Immunologically, SLE is char-
acterised by the presence of antinuclear autoanti-
bodies, especially against double-stranded DNA 
and nucleosomes, activation of the complement 
system during ﬂ  ares, and type I interferon secre-
tion.15 16 The aetiology of SLE remains elusive, but 
an interplay of genetic and environmental factors is 
considered to ultimately cause immune dysregula-
tion, resulting in clinical symptoms. Many genetic 
variants on different chromosomes together with 
more than 31 different candidate genes have been 
reported and were conﬁ  rmed as susceptibility loci 
for SLE by replication studies.17–20 A well-known 
susceptibility locus for SLE is the major histocom-
patibility complex (MHC) region on chromosome 
6p21, which is linked to multiple autoimmune dis-
eases.21 Mainly alleles of the MHC class II region 
such as human leucocyte antigen (HLA)-DR2 and 
HLA-DR3 were found to be associated with SLE, 
especially in Caucasians22 23; however, the exact 
mechanism by which these HLA molecules con-
tribute to the immunopathogenesis is unknown. 
Owing to the extent of local linkage disequilibrium 
(LD), it is not yet clear whether the susceptibility 
to the disease is directly and exclusively associated 
with the products of speciﬁ  c MHC alleles or of a 
combination of certain MHC alleles with alleles of 
other linked genes, or just with certain polymor-
phisms of linked genes. Therefore, other genes 
mapping to the MHC loci have been considered to 
be additional candidates for disease susceptibility 
such as complement C2 and C4, tumour necrosis 
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factor α,24 21-hydroxylase and the superkiller viralicidic activ-
ity 2-like (Saccharomyces cerevisiae) gene (SKIVL2).25 In humans, 
three members of the Hsp70 gene family, referred to as Hsp70-1 
(HspA1A), Hsp70-2 (HspA1B) and Hsp70-Hom (HspA1L), have 
been mapped to this MHC class III locus.26 Proteins of the 
Hsp70 family are commonly among the most highly conserved 
proteins known. Subtle genetic variations can result in diversi-
ﬁ  ed thermotolerance between species27 and may also be impor-
tant determinants for the speciﬁ  c propagation of diseases such 
as SLE.
In this study, we examined a potential genetic association of 
the Hsp70 locus on chromosome 6p21.33a with SLE. In two 
independent Caucasian case–control studies, we found one hap-
lotype to be signiﬁ  cantly associated with SLE.
PATIENTS AND METHODS
Study population and clinical evaluation
A cohort of 212 unrelated well-documented German patients 
with SLE (184 women, 28 men) from the Department of 
Internal Medicine 3, University of Erlangen–Nuremberg, were 
randomly selected irrespective of stage or severity of the dis-
ease. All patients fulﬁ  lled the criteria of the American College 
of Rheumatology for the diagnosis of SLE.15 16 A median of 
13 visits was recorded for each patient, varying from 1 to 
54, and the follow-up period extended from 1985 to 2006. 
Autoantibodies against double-stranded DNA were present 
in 99% of our SLE cohort, at least at some time during the 
course of the disease. All abnormalities associated with SLE 
were recorded from the ﬁ  rst visit either in Erlangen or from a 
well-documented history and at each follow-up visit. A group 
of 223 healthy unrelated donors volunteered as controls. The 
study was approved by the ethics committee of the University 
of Erlangen–Nuremberg, and written informed consent was 
obtained from all participants.
A second cohort consisting of 934 unrelated American patients 
with SLE and normal healthy donors of European descent from 
the Lupus Family Registry and Repository (http://lupus.omrf.
org) was kindly provided by the Oklahoma Medical Research 
Foundation (OMRF). Data on autoantibody titres were derived 
from both medical records and Clinical Laboratory Improvement 
Act-approved laboratory data.
Genotyping methods
Genomic DNA was isolated from 0.5 ml peripheral blood using 
standard procedures. Identiﬁ  cation of haplotypes was performed 
with the Haploview 3.2 CI method based on the HapMap Data 
release 21 (http://www.hapmap.org/). Five different tagging 
single-nucleotide polymorphisms (SNPs) (rs2075800, rs2227956, 
rs1043618, rs2763979, rs3115673) were selected on the basis 
of LD to discriminate the major haplotypes of the Hsp70 gene 
locus that are present with a frequency above 1% in the Centre 
d’Etude du Polymorphisme Humaine (CEPH) population. 
Genotyping was carried out in an iCycler real-time PCR setup 
(Bio-Rad, Munich, Germany) using TaqMan SNP Genotyping 
Assays and TaqMan Universal PCR Master Mix, No AmpErase 
UNG (Applied Biosystems, Darmstadt, Germany).
Blood samples
Venous blood was collected from healthy donors and patients 
with SLE in 20 ml heparin-containing tubes for isolation of 
cells, or without anticoagulant for serum (Monovette; Sarstedt, 
Nuembrecht, Germany). Serum samples were centrifuged at 
2000 g for 30 min at 4°C and stored at −20°C.
Cell culture
The human cell line HEK293T (CRL-11268; ATCC, Wesel, 
Germany) and peripheral blood mononuclear cells (PBMCs) 
were grown in Dulbecco’s modiﬁ  ed Eagle medium containing 
10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, 
100 μg/ml streptomycin (all from Invitrogen Life Technologies, 
Karlsruhe, Germany) at 5% CO2 and 37°C. PBMCs were iso-
lated as described previously.28 Heat shock treatment was car-
ried out for 2 h at 42°C followed by a recovery period (37°C) 
either for 3 h for subsequent RNA isolation or overnight for 
western blotting.
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
(SDS-PAGE) and western blotting
Isolated PBMCs lysed in 50 μl SDS-PAGE sample buffer were 
subjected to SDS-PAGE as described.29 Proteins were transferred 
on to a nitrocellulose membrane (Millipore, Bedford, UK) using 
semidry apparatus (Serva, Heidelberg, Germany) according to 
the manufacturer’s recommendations. After blocking (5% (w/v) 
milk powder, 10 mM Tris/HCl, 100 mM NaCl, 0.05% (v/v) 
Tween-20, pH 7.4), primary antibodies against Hsp72 (1:30 000) 
(SPA-812; Biomol, Hamburg, Germany) and β-actin (1:1000) 
(Sigma-Aldrich, Hamburg, Germany) were applied. After 
washing, blots were incubated with secondary IRDye 800CW 
goat anti-rabbit antibody (1:10 000) (LI-COR Bioscience, Bad 
Homburg, Germany). Integrated intensity of the bands was 
quantiﬁ  ed using the Odyssey infrared imaging system (LI-COR 
Bioscience).
RNA isolation and quantitative PCR
Total RNA was extracted from 2 × 106 PBMCs using the RNeasy 
kit (Qiagen, Hilden, Germany). cDNA was prepared with 
Moloney murine leukaemia virus reverse transcriptase (Promega, 
Mannheim, Germany) and oligo(dT)20 primers according to the 
manufacturer’s instructions. Quantiﬁ  cation of cDNA was car-
ried out using ABsolute QPCR SYBR Green ROX Mix (Thermo 
Fisher Scientiﬁ   c, Schwerte, Germany) in a StepOnePlus 
Real-Time PCR System (Applied Biosystems) with the follow-
ing primers: HspA1A, 5′-GCTGCTGCGACAGTCCACTAC-3′ 
and 5′ -CCCTGCTCTCTGTCGGCTCGGC-3′ ; 
HspA1B, 5′-AGCTGCTGCGAGGGTCCGCTTC-3′ 
and 5′ -GTGCCCTGCTCTGTGGGCTCC-3′ ; 
HspA1L, 5′-ACAGGGTATGTGCCTGGAAG-3′ and 
5′-GGTGGTGCATGAGACTCCTT-3′;  GAPDH, 
5 ′ -CATGAGAAGTATGACAACAGCCT-3′  and  
5′-AGTCCTTCCACGATACCAAAGT-3′. Relative quanti-
ﬁ  cation of cDNA was based on the comparative Ct method 
using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as 
endogenous control. ΔCt levels were calculated in triplicate for 
four different donors of each genotype and normalised to one 
randomly selected donor homozygous for cytosine.
Stratiﬁ  cation analysis
Principal component analysis (PCA) was performed using 
Eigensoft30 on 905 of the 934 Oklahoma samples using case–
control data from 17 875 SNPs collected from a separate candi-
date gene study. After removal of genetic outliers (12 cases and 
7 controls), 493 cases and 393 controls remained for analysis. We 
then performed genomic control analysis to calculate the inﬂ  a-
tion factor (λ), which produced a value of 1.21 for these samples 
(the value for the pretrimmed sample was 1.24). After trim-
ming of the sample, we performed a logistic regression analysis 
using the PCA values as covariates, using PLINK31 to remove 
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LD depicted in the LD plot (ﬁ  gure 1C). All observed SNP allele fre-
quencies were concordant with those reported in the NCBI dbSNP 
database, and the genotype frequencies were in Hardy–Weinberg 
equilibrium. In the Erlangen cohort, polymorphism Hsp70-4 was 
identiﬁ  ed to be signiﬁ  cantly associated with SLE (p=0.016). The 
major allele of this SNP, cytosine, was present in 61% of patients 
with SLE compared with 69% in controls, suggesting either cyto-
sine as a protective allele or thymine as part of a risk allele for SLE. 
Two reconstructed haplotypes were also strongly associated with 
SLE, with C–A–C–T–G being more frequently (p=0.0022) present 
in patients with SLE (26%) than in controls (17%). Conversely, 
the haplotype C–A–C–C–G (p=0.0444) was found more fre-
quently in healthy individuals (table 1). In addition, we analysed 
whether haplotypes have independent or interactive effects. By 
testing each haplotype against all others, we found that only the 
risk-conferring (p=0.0018) and protective (p=0.045) haplotypes 
are signiﬁ  cant in the haplotype-speciﬁ  c test. Even when all hap-
lotype effects were tested together in an interaction model, only 
this combined haplotype was found to be signiﬁ  cant.
Genotyping of the second cohort, OMRF, was performed only 
for SNPs Hsp70-4 and Hsp70-5, because the two signiﬁ  cantly 
associated haplotypes C–A–C–T–G and C–A–C–C–G can be 
identiﬁ  ed by these SNPs. In this independent replication cohort, 
the genetic associations of both SNP Hsp70-4 and the represen-
tative haplotypes T–G and C–G, respectively, were conﬁ  rmed 
with even higher signiﬁ  cance (table 2). Combined analysis of 
both cohorts reached a p value of 3.64×10−7 for the haplotype 
T–G and 0.0002 for SNP Hsp70-4.
To determine the effect size of SNP Hsp70-4 and the Hsp70 
haplotypes for SLE, ORs were calculated using unstratiﬁ  ed 
the ﬁ  nal source of confounding via admixture, which produced 
a corrected p=0.0145 (OR=1.292) at rs2763979 and p=0.4762 
(OR=0.903) at rs3115673 in these samples.
Conditional regression analysis
For the OMRF samples, a surrogate SNP (rs3129860) was cho-
sen from the OMRF Lupus Large Association Study 1 (LLAS1) 
data that is in strong LD (r2=0.95) with the HLA-DRB1 tagging 
SNP (rs701831). Conditional regression analysis was performed 
with the surrogate SNP and SNP Hsp70-4 on the OMRF samples 
using PLINK31.
Statistical analysis
Statistical analysis for the case–control study was carried out 
with the Haploview V3.32 software package.32 Haplotype-based 
association testing was carried out using PLINK.31 The Fisher 
exact test and Mann–Whitney U test were performed with 
Prism 4 software. p Values <0.05 were considered signiﬁ  cant.
RESULTS
Genetic association of Hsp70 haplotypes with SLE
To investigate a possible contribution of Hsp70 polymorphisms 
to SLE susceptibility, we performed a case–control association 
study followed by an independent replication study. As shown 
in ﬁ  gure 1A, the three intronless Hsp70 genes, HspA1L, HspA1A 
and HspA1B, are located on chromosome 6p21.33a. On the basis 
of information on the CEPH population provided by the HapMap 
database, we selected ﬁ  ve haplotype-tagging SNPs to deﬁ  ne hap-
lotypes with more than 1% frequency (ﬁ  gure 1B) and with high 
Figure 1  Overview and linkage disequilibrium (LD) of the human genomic locus containing three Hsp70 genes on chromosome 6. (A) The human 
susceptibility locus for systemic lupus erythematosus on chromosome 6p21.33 covers a cluster of three Hsp70 genes: HspA1L, HspA1A and 
HspA1B. (B) On the basis of LD, ﬁ  ve haplotype-tagging single-nucleotide polymorphisms (SNPs) were selected to identify the major haplotypes (>1% 
frequency). (C) LD prime charts generated using Haploview V3.32 software summarise LD patterns in Caucasians (Centre d’Etude du Polymorphisme 
Humaine). Dark red boxes represent regions of high pairwise r2, whereas bright red boxes show lower pairwise r2. The numbers in the boxes depict 
pairwise r2 values, with empty cells representing pairwise r2=1.
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genotyping data. For our newly identiﬁ  ed SNP, Hsp70-4, the OR 
for donors bearing a T allele is 1.43 (95% CI 1.08 to 1.89) and 
1.3 (95% CI 1.07 to 1.58) for the Erlangen and OMRF cohort, 
respectively. When the analysis was performed for haplotypes, 
the OR for patients bearing one T–G haplotype compared with 
those homozygous for C–G is 1.88 (95% CI 1.18 to 3.02) in the 
Erlangen cohort and 1.43 (95% CI 1.04 to 1.96) in the OMRF 
cohort. When homozygous donors for T–G and C–G are com-
pared, the OR is 2.64 (95% CI 1.02 to 6.85) and 3.16 (95% CI 1.67 
to 5.97) in the Erlangen and OMRF cohort, respectively (table 3).
Conditional regression analysis
The distance between the three Hsp70 genes, located in the MHC 
class III region, and HLA-DRB1 (MHC class II) is ~1 Mb. The LD 
plot for European-derived samples genotyped in the International 
HapMap Project (online supplementary ﬁ  gure 1) shows incom-
plete linkage in this region. However, owing to long-range linkage 
in this entire locus, we performed conditional regression analysis 
to investigate whether the genetic association of SNP Hsp70-4 is 
independent of HLA-DRB1. One surrogate SNP (rs2763979) that 
shows strong LD with SNP rs701831 in HLA-DRB1 was chosen 
Table 1  Genetic association of Hsp70 haplotypes with SLE in the Erlangen cohort
SNP No rs No Major/minor allele
Frequency of major allele (%) Single marker association
SLE (n=212) Controls (n=223) (p value)
Hsp70-1 rs2075800 C/T 68.0 65.7 0.4792
Hsp70-2 rs2227956 A/G 81.4 83.0 0.5483
Hsp70-3 rs1043618 G/C 60.2 65.3 0.1306
Hsp70-4 rs2763979 C/T 61.0 68.8 0.0160
Hsp70-5 rs3115673 G/T 88.3 87.4 0.6902
Haplotype Overall frequency
Frequency of haplotype (%) Haplotype association
SLE (n=212) Controls (n=223) (p value)
T–A–G–C–G 32.7 32.1 33.3 0.7034
C–A–C–T–G 21.4 25.8 17.2 0.0022
C–G–G–C–G 16.5 16.2 16.8 0.7999
C–A–C–T–T 9.2 9.0 9.5 0.8023
C–A–G–C–G 8.3 6.9 9.7 0.1455
C–A–C–C–G 6.4 4.7 8.1 0.0444
C–A–G–T–T 2.9 2.6 3.1 0.6311
SLE, systemic lupus erythematosus; SNP, single-nucleotide polymorphism.
Table 2  Replication study of the genetic association of Hsp70 haplotypes with SLE in the OMRF cohort
SNP No rs No Major/minor allele
Frequency of major allele (%) Single marker association
SLE (n=519) Controls (n=415) (p value)
Hsp70-4 rs2763979 C/T 59.3 65.5 0.0071
Hsp70-5 rs3115673 G/T 87.7 86.5 0.4614
Haplotype Overall frequency
Frequency of haplotypes (%) Haplotype association
SLE (n=519) Controls (n=415) (p value)
C–G 60.9 57.7 64.9 0.0018
T–G 26.2 29.8 21.7 0.000074
T–T 11.7 10.8 12.8 0.1963
C–T 1.2 1.6 0.6 0.0665
OMRF, Oklahoma Medical Research Foundation; SLE, systemic lupus erythematosus; SNP, single-nucleotide polymorphism.
Table 3  ORs for SNP Hsp70-4 and different Hsp70 haplotypes comparing patients with SLE with healthy 
controls
Population: OR for SNP Hsp70-4 alleles OR p Value 95% CI
Erlangen (n=435)
  C versus T 1.43 0.01 1.08 to 1.89
OMRF (n=934)
  C versus T 1.30 0.008 1.07 to 1.58
Population: OR for haplotypes OR p Value 95% CI
Erlangen (n=435)
  C–G/C–G versus C–G/T–G 1.88 0.009 1.18 to 3.02
  C–G/C–G versus T–G/T–G 2.64 0.06 1.02 to 6.85
OMRF (n=934)
  C–G/C–G versus C–G/T–G 1.43 0.03 1.04 to 1.96
  C–G/C–G versus T–G/T–G 3.16 < 0.001 1.67 to 5.97
ORs were calculated using the Fisher exact test.
OMRF, Oklahoma Medical Research Foundation; SLE, systemic lupus erythematosus.
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from the OMRF LLAS1 genotyping data, as the HLA-DRB1 tag-
ging SNP itself was not included in LLAS1 dataset. We found that 
SNP Hsp70-4 (rs2763929) acts independently of the HLA-DRB1 
surrogate (p=0.019) and vice versa (p=0.045).
Correlation of the haplotype T–G with clinical variables in 
patients with SLE
To examine a potential effect of the risk haplotype T–G on 
disease manifestation, we correlated clinical variables of the 
Erlangen cohort with the associated haplotypes in a cumula-
tive analysis. Patients with haplotype T–G were signiﬁ  cantly 
more frequently positive for anti-Ro and anti-La autoantibody 
responses, lupus anticoagulant and oronasal ulcers than those 
with haplotype C–G (online supplementary ﬁ  gure 2A). In con-
trast, when SLE patients bearing HLA-DR3 alleles were com-
pared with those lacking an HLA-DR3 allele (HLA-DRx/x), no 
statistically signiﬁ  cant correlations with clinical or immunologi-
cal disease variables could be detected (online supplementary 
ﬁ  gure 2B). These data also indicate that the Hsp70 haplotype 
T–G contributes independently of HLA-DR3 to the manifesta-
tion of SLE. As depicted in table 4, patients either heterozygous 
or homozygous for allele T or for the haplotype T–G were more 
frequently positive for anti-Ro and anti-La autoantibodies in 
both SLE cohorts.
Increased mRNA expression of HspA1A in PBMCs from healthy 
donors homozygous for thymine at SNP Hsp70-4
SNP Hsp70-4 is located between the genes for HspA1A and 
HspA1B, thus allelic variations at this position may inﬂ  uence the 
expression of HspA1A and HspA1B. To prevent the inﬂ  uence of 
medication, we used PBMCs from 12 healthy donors who were 
either homozygous for thymine or cytosine or were heterozy-
gous at SNP Hsp70-4. Figure 2A,B shows a signiﬁ  cantly increased 
expression of HspA1A mRNA in healthy donors homozygous or 
heterozygous for thymine compared with homozygous carriers 
of cytosine, both under physiological conditions (ﬁ  gure 2A) and 
after heat stress (ﬁ  gure 2B). In contrast, we detected no signiﬁ  cant 
differences in mRNA levels for either HspA1B or HspA1L under 
all conditions tested. In accordance with other reports,33 HspA1A 
and HspA1B were found to be strongly heat inducible, whereas 
HspA1L was weakly induced after heat stress (data not shown). 
To further investigate the expression of the three Hsp70 genes 
(HspA1L, HspA1A and HspA1B), the total amount of all three 
Hsp72 proteins was determined by western blot   (ﬁ  gure 2C), as 
Figure 2  Inﬂ  uence of Hsp70 polymorphisms on Hsp70 mRNA and protein expression. Primary human peripheral blood mononuclear cells (PBMCs) 
from donors with deﬁ  ned genotypes were analysed for relative expression of HspA1L, HspA1A and HspA1B mRNA under physiological conditions 
(A) or after heat shock (B). Data in (A) and (B) are expressed in arbitrary units that represent one out of three independent experiments. Statistical 
analyses were performed using the Mann–Whitney U test. p Values <0.05 were considered signiﬁ  cant. (C) Primary human PBMCs with or without 
heat shock treatment were analysed for total Hsp72 protein expression. The integrated intensity of the bands for Hsp72 and β-actin were quantiﬁ  ed. 
Data represent the mean result of three independent experiments.
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Polymorphisms in HspA1L (2437, coding), HspA1A (−110, 5′ ﬂ  ank-
ing; and 190, 5′ untranslated region) and HspA1B (1267, coding) 
have been discovered to correlate with increased longevity in 
Danish populations.35 36 Most Hsps can positively inﬂ  uence cel-
lular maintenance and repair mechanisms through their chaperone 
activity.37–39 Therefore Hsps are generally recognised as protective 
elements increasingly gaining attention in relation to diseases and 
immunological processes.6 Associations of polymorphisms within 
the three Hsp70 genes with Ménière’s disease,40 noise-induced 
hearing loss,41 high-altitude pulmonary oedema42 and coronary 
heart disease43 have recently been discovered. In these reports, 
major importance was determined for two SNPs in HspA1A that 
are located at positions −110 (rs1008438) and +190 (rs1043618), 
the latter also being part of our study (Hsp70-3). As we found a 
genetic association for the haplotypes T–G and C–G (Hsp70-4 and 
Hsp70-5) with SLE, we stratiﬁ  ed the samples according to SNP 
Hsp70-4 for functional analyses and discovered differences in 
mRNA regulation for HspA1A (ﬁ  gure 2A,B). In spite of divergent 
mRNA concentrations for HspA1A, the protein expression level of 
all three Hsp70 genes was not altered in PBMCs from different 
donors either under steady-state conditions or after heat shock 
(ﬁ  gure 2C), which might be a result of negative transcriptional 
feedback regulation. Whether increased transcription of HspA1A 
mRNA is functionally relevant for the pathogenesis of SLE remains 
to be elucidated. Because of the extent of LD, we are currently 
unable to rule out indirect effects that might arise from poten-
tially causal variants of Hsp70-3 or other unknown factors. As we 
have analysed the expression of Hsp70 genes in PBMCs, a tissue-
speciﬁ  c expression of Hsp70 is possible and may be relevant for 
SLE. Because of long-range linkage in the lupus-associated DR3 
‘autoimmune’ extended haplotype, we performed conditional 
regression analysis to investigate if the associated SNP Hsp70-4 
acts independently of HLA-DR3. Tracking HLA-DR3 using a sur-
rogate SNP, we found SNP Hsp70-4 to be independent, and vice 
versa. These results are in accordance with recent investigations 
carried out by high-density screening of the MHC genes, produc-
ing strong evidence for independent susceptibility regions in the 
MHC locus.44 In addition, we showed that the Hsp70 haplotype 
T–G, as well as the SNP Hsp70-4, correlated in both cohorts with 
the presence of autoantibodies to Ro and La in patients with SLE.
In summary, our data indicate an important role for Hsp70 
molecules in the aetiology and pathogenesis of SLE, consistent 
with the involvement of Hsp70 molecules in antigen delivery 
and presentation as well as protein folding and homoeostasis.
Acknowledgements  We thank Gerhard Groer for critical reading of the manuscript, 
Rüdiger Müller for help with statistical analyses, and Birgit Lauer for HLA genotyping. 
Portions of the samples used in this study were obtained from the Lupus Family 
Registry and Repository (AR62277) (see http://lupus.omrf.org).
Funding  This study was supported by the Interdisciplinary Center of Clinical Research 
(IZKF) of the University Hospital Erlangen, project N2. This work has been supported 
by the National Institutes of Health (grants AI24717, AR62277, AR42460, AR49084, 
RR20143, AR053483, N01-AI-50026, P20RR015577), the Mary Kirkland Scholarship, 
the Alliance for Lupus Research and the US Department of Veterans Affairs.
Competing interests None.
Patient consent Obtained.
Ethics approval  This study was conducted with the approval of the ethics 
committee of the Medical Faculty of the University of Erlangen-Nuremberg.
Provenance and peer review  Not commissioned; externally peer reviewed.
REFERENCES
 1.  Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996;381:571–9.
 2.  Buchner J. Supervising the fold: functional principles of molecular chaperones. 
FASEB J 1996;10:10–19.
gene products are 99% identical and currently indistinguishable 
by available antibodies. The overall Hsp72 protein level was not 
altered in PBMCs from donors with thymine or cytosine at SNP 
Hsp70-4, when kept at 37°C or after heat shock. To examine a 
potential direct inﬂ  uence of genotypes of SNP Hsp70-4, located 
upstream of the HspA1B promoter, on the expression of HspA1B, 
the promoter activity was analysed by reporter assays (online 
supplementary methods and supplementary ﬁ  gure 3). The pro-
moter of HspA1B was highly inducible by heat stress and to a 
lower extent by osmotic shock. In agreement with mRNA quan-
tiﬁ  cation in PBMCs of healthy donors, similar luciferase activi-
ties for both promoter constructs were reproducibly observed 
for all conditions tested, arguing against a direct effect of SNP 
Hsp70-4 on the promoter activity of HspA1B.
DISCUSSION
In our study, we identiﬁ  ed one haplotype (T–G) in the Hsp70 
locus as a potential genetic risk factor for SLE using a haplotype-
tagging SNP approach and conﬁ  rmed the genetic association in an 
independent case–control cohort. In a cumulative analysis, this 
haplotype correlated in SLE patients with the presence of clinical 
variables such as autoantibodies to Ro and La, as well as lupus 
anticoagulant. To our knowledge this is the ﬁ  rst genetic associa-
tion study on autoimmune diseases such as SLE that takes into 
account the entire Hsp70 locus on 6p21.33 with respect to the 
underlying LD. Previous studies aimed to identify individual SNPs, 
such as the 8.5 kb PstI polymorphism at position 1267 within the 
HspA1B coding region representing a silent mutation. This SNP 
has been found to be associated with SLE in African–Americans 
and in a Spanish, but not a Mexican Mestizo, population.13 14 34 
Table 4  ORs for SLE patients with different Hsp70-4 genotypes and 





against p Value OR 95% CI
Erlangen Ro
  C/C versus T/T 0.02 2.74 1.15 to 6.52
  C/C versus C/T 0.02 2.15 1.12 to 4.13
La
  C/C versus T/T 0.02 3.01 1.18 to 7.70 
  C/C versus C/T NS 1.36 0.63 to 2.97
OMRF Ro
  C/C versus T/T NS 1.27 0.68 to 2.37
  C/C versus C/T 0.03 1.67 1.04 to 2.68
La
  C/C versus T/T 0.02 2.73 1.12 to 6.65




against p Value OR 95% CI
Erlangen Ro
  C–G/C–G versus T–G/T–G 0.004 5.14 1.57 to 16.84
  C–G/C–G versus C–G/T–G 0.001 3.21 1.58 to 6.53
La
  C–G/C–G versus T–G/T–G 0.01 4.17 1.29 to 13.55
  C–G/C–G versus C–G/T–G NS 1.91 0.85 to 4.29
OMRF Ro
  C–G/C–G versus T–G/T–G NS 1.65 0.78 to 3.50
  C–G/C–G versus C–G/T–G NS 1.65 0.97 to 2.69
La
  C–G/C–G versus T–G/T–G 0.05 2.72 0.97 to 7.66
  C–G/C–G versus C–G/T–G 0.007 2.81 1.30 to 6.05
ORs were calculated using χ2 test.
OMRF, Oklahoma Medical Research Foundation; SLE, systemic lupus erythematosus.
16_annrheumdis122630.indd   1988 16_annrheumdis122630.indd   1988 9/30/2010   8:35:39 PM 9/30/2010   8:35:39 PMExtended report
Ann Rheum Dis 2010;69:1983–1989. doi:10.1136/ard.2009.122630 1989
24.  Rood MJ, van Krugten MV, Zanelli E, et al. TNF-308A and HLA-DR3 alleles contribute 
independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 
2000;43:129–34.
25.  Fernando MM, Stevens CR, Sabeti PC, et al. Identiﬁ  cation of two independent 
risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 
2007;3:e192.
26.  Milner CM, Campbell RD. Polymorphic analysis of the three MHC-linked HSP70 
genes. Immunogenetics 1992;36:357–62.
27.  Favatier F, Bornman L, Hightower LE, et al. Variation in hsp gene expression and 
Hsp polymorphism: do they contribute to differential disease susceptibility and stress 
tolerance? Cell Stress Chaperones 1997;2:141–55.
28.  Böttcher A, Gaipl US, Fürnrohr BG, et al. Involvement of phosphatidylserine, 
alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary 
necrotic lymphocytes by macrophages. Arthritis Rheum 2006;54:927–38.
29.  Laemmli UK. Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 1970;227:680–5.
30.  Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for 
stratiﬁ  cation in genome-wide association studies. Nat Genet 2006;38:904–9.
31.  Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-
genome association and population-based linkage analyses. Am J Hum Genet 
2007;81:559–75.
32.  Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and 
haplotype maps. Bioinformatics 2005;21:263–5.
33.  Milner CM, Campbell RD. Structure and expression of the three MHC-linked HSP70 
genes. Immunogenetics 1990;32:242–51.
34.  Vargas-Alarcón G, Granados J, Martínez-Laso J, et al. Lack of association 
between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic 
lupus erythematosus (SLE) in the Mexican mestizo population. Genes Immun 
2000;1:367–70.
35.  Singh R, Kølvraa S, Bross P, et al. Heat-shock protein 70 genes and human longevity: 
a view from Denmark. Ann N Y Acad Sci 2006;1067:301–8.
36.  Singh R, Kolvraa S, Rattan SI. Genetics of human longevity with emphasis on the 
relevance of HSP70 as candidate genes. Front Biosci 2007;12:4504–13.
37.  Morimoto RI, Santoro MG. Stress-inducible responses and heat shock proteins: new 
pharmacologic targets for cytoprotection. Nat Biotechnol 1998;16:833–8.
38.  Li Z, Srivastava P. Heat-shock proteins. Curr Protoc Immunol 2004;Appendix 
1:Appendix 1T.
39.  Macario AJ, Conway de Macario E. Chaperonopathies and chaperonotherapy. FEBS 
Lett 2007;581:3681–8.
40.  Kawaguchi S, Hagiwara A, Suzuki M. Polymorphic analysis of the heat-shock protein 
70 gene (HSPA1A) in Ménière’s disease. Acta Otolaryngol 2008;128:1173–7.
41.  Konings A, Van Laer L, Michel S, et al. Variations in HSP70 genes associated 
with noise-induced hearing loss in two independent populations. Eur J Hum Genet 
2009;17:329–35.
42.  Qi Y, Niu WQ, Zhu TC, et al. Genetic interaction of Hsp70 family genes polymorphisms 
with high-altitude pulmonary edema among Chinese railway constructors at altitudes 
exceeding 4,000 meters. Clin Chim Acta 2009;405:17–22.
43.  He M, Guo H, Yang X, et al. Functional SNPs in HSPA1A gene predict risk of coronary 
heart disease. PLoS ONE 2009;4:e4851.
44.  Barcellos LF, May SL, Ramsay PP, et al. High-density SNP screening of the major 
histocompatibility complex in systemic lupus erythematosus demonstrates strong 
evidence for independent susceptibility regions. PLoS Genet 2009;5:e1000696.
 3.  Zügel U, Kaufmann SH. Role of heat shock proteins in protection from and 
pathogenesis of infectious diseases. Clin Microbiol Rev 1999;12:19–39.
 4.  De Nagel DC, Pierce SK. Heat shock proteins implicated in antigen processing and 
presentation. Semin Immunol 1991;3:65–71.
 5.  Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev 
Immunol 2002;2:185–94.
 6.  Nardai G, Végh EM, Prohászka Z, et al. Chaperone-related immune dysfunction: an 
emergent property of distorted chaperone networks. Trends Immunol 2006;27:74–9.
 7.  Soti C, Pál C, Papp B, et al. Molecular chaperones as regulatory elements of cellular 
networks. Curr Opin Cell Biol 2005;17:210–15.
 8.  Ramachandran S, Bell RB. Heat shock protein 70 gene polymorphisms and multiple 
sclerosis. Tissue Antigens 1995;46:140–1.
 9.  Debler J, Schiemann U, Seybold U, et al. Heat-shock protein HSP70-2 genotypes 
in patients with Crohn’s disease: a more severe clinical course with intestinal 
complications in presence of the PstI-polymorphism. Eur J Med Res 2003;8:120–4.
10.  Clarimón J, Bertranpetit J, Boada M, et al. HSP70-2 (HSPA1B) is associated with 
noncognitive symptoms in late-onset Alzheimer’s disease. J Geriatr Psychiatry Neurol 
2003;16:146–50.
11.  Ratanachaiyavong S, Demaine AG, Campbell RD, et al. Heat shock protein 70 
(HSP70) and complement C4 genotypes in patients with hyperthyroid Graves’ disease. 
Clin Exp Immunol 1991;84:48–52.
12.  Pociot F, Rønningen KS, Nerup J. Polymorphic analysis of the human MHC-linked 
heat shock protein 70 (HSP70-2) and HSP70-Hom genes in insulin-dependent 
diabetes mellitus (IDDM). Scand J Immunol 1993;38:491–5.
13.  Jarjour W, Reed AM, Gauthier J, et al. The 8.5-kb PstI allele of the stress protein 
gene, Hsp70-2: an independent risk factor for systemic lupus erythematosus in 
African Americans? Hum Immunol 1996;45:59–63.
14.  Pablos JL, Carreira PE, Martín-Villa JM, et al. Polymorphism of the heat-
shock protein gene HSP70-2 in systemic lupus erythematosus. Br J Rheumatol 
1995;34:721–3.
15.  Hochberg MC. Updating the American College of Rheumatology revised 
criteria for the classiﬁ  cation of systemic lupus erythematosus. Arthritis Rheum 
1997;40:1725.
16.  Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classiﬁ  cation of 
systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
17.  Cantor RM, Yuan J, Napier S, et al. Systemic lupus erythematosus genome scan: 
support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 
3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum 2004;50:3203–10.
18.  Gaffney PM, Kearns GM, Shark KB, et al. A genome-wide search for susceptibility 
genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci 
USA 1998;95:14875–9.
19.  Gray-McGuire C, Moser KL, Gaffney PM, et al. Genome scan of human systemic 
lupus erythematosus by regression modeling: evidence of linkage and epistasis at 
4p16-15.2. Am J Hum Genet 2000;67:1460–9.
20.  Nath SK, Namjou B, Hutchings D, et al. Systemic lupus erythematosus (SLE) and 
chromosome 16: conﬁ  rmation of linkage to 16q12-13 and evidence for genetic 
heterogeneity. Eur J Hum Genet 2004;12:668–72.
21.  Wakeland EK, Liu K, Graham RR, et al. Delineating the genetic basis of systemic 
lupus erythematosus. Immunity 2001;15:397–408.
22.  Arnett FC. Genetic aspects of human lupus. Clin Immunol Immunopathol 
1992;63:4–6.
23.  Tan FK, Arnett FC. The genetics of lupus. Curr Opin Rheumatol 1998;10:399–408.
16_annrheumdis122630.indd   1989 16_annrheumdis122630.indd   1989 9/30/2010   8:35:39 PM 9/30/2010   8:35:39 PM